Growth Potential / Upcoming Products & Services:

Caduceus Software Systems Corp. (CSOC) is a software company that specializes in developing an all-in-one solution for private practioners and doctors. They are in the booming healthcare information management industry.

CSOC was created as they saw an urgent need for better patient care throughout the world. General practitioners are using unsophisticated software acts as more administrative than act as a time saving tool.

The flagship product is called Caduceus MMS version 1.0. It is a sophisticated appointment scheduling and patient recording software system. It has the capability to add more functionality as needed by the doctors that use it.

Product Overview at a Glance

Caduceus MMS v 1.0 is a scalable system. The MMS system can work for single and multi-user office environments. Doctors can view sensitive patient information, medical office assistants can set up appoints, and larger offices can have multi-task assignments of access. You can add modules to the system for specialized services, ideal for specialists.

Introducing Caduceus MMS version 1.0

Caduceus Software Systems is pleased to announce that it has released Caduceus MMS version 1.0. Caduceus MMS is a revolutionary healthcare information management software system. It has appointment scheduling and patient charting capabilities – a solution for the ENTIRE private clinic. Doctors love it because they can record paitent notes and ailments digitally, their supporting administration staff love it because they can manage the booking of upcoming appointments. Doctors and their staff both love it because they are in sync.

Caduceus MMS

Caduceus Software Systems Corp. is heralding the start of a new era in medical health recordkeeping — Caduceus Medical Management System or, more commonly, Caduceus MMS. This new software platform is a revolutionary departure from current medical billing software offerings.

Unlike most Electronic Medical Billing Software (EMBS) that provide limited scope and depth, Caduceus Medical Management System (Caduceus MMS) embodies all areas needed to efficiently manage any kind of healthcare practice. For instance, the status quo has been to present applications that incorporate either appointment scheduling or service billing, but rarely both, and certainly not much more. The competition believes that merely simpler is better. Unfortunately, the daunting outcome to the practitioner is to try to coordinate the functions of many programs to perform the tasks that one, intuitive, yet all encompassing, software package should provide.

Caduceus intelligently expands upon and supercedes the average expectation by bestowing upon our users elements that are vital, but often overlooked, when designing data-entry software architectures: all functions that are required to manage a practice from patient entry to remittance; a consistent layout that reduces the stress due to learning how to operate the software; program flow that is deductive, and; intuitive handling of data.

Caduceus MMS is a feature-rich software program with a dynamic array of tools geared to maximize the efficiency of your practice. Whether you are a novice or an expert in clinical management, Caduceus MMS offers has the right features necessary to get professional-quality results.

It excels as a quality control tool for patient administration, appointment scheduling, service billing, practitioner controls, record-keeping, reporting, submissions, and much more. Its extensive features are innovative and dynamic in all facets of the administrative process and enables management to plan ahead for optimum growth.

Industry:

Ranked as one of the best industries to start a business by in.com, software-as-a-service niche (Such as medical related software) is forecast to expand by nearly 20 percent annually over the next few years. Companies should continue to see the benefits of on-demand, flexible applications, according to Gartner, a market-research firm. The industry is expected to produce $8 billion in sales by the end of this year and $16 billion by the end of 2013. The office suites categories will lead the pack this year, increasing 376 percent to $512 million.

Let’s look closer at Electronic Medical Records (EMR’s) as a whole…

Paper based records are still by far the most common method of recording patient information for most hospitals and practices in the U.S. The majority of doctors still find their ease of data entry and low cost hard to part with. However, as easy as they are for the doctor to record medical data at the point of care, they require a significant amount of storage space compared to digital records. In the US, most states require physical records be held for a minimum of seven years. The costs of storage media, such as paper and film, per unit of information differ dramatically from that of electronic storage media.

When paper records are stored in different locations, collating them to a single location for review by a health care provider is time consuming and complicated, whereas the process can be simplified with electronic records. This is particularly true in the case of person-centred records, which are impractical to maintain if not electronic (thus difficult to centralise or federate.

When paper-based records are required in multiple locations, copying, faxing, and transporting costs are significant compared to duplication and transfer of digital records. Because of these many "after entry" benefits, federal and state governments, insurance companies and other large medical institutions are heavily promoting the adoption of electronic medical records.

Congress included a formula of both incentives (up to $44K per physician under Medicare or up to $65K over 6 years, under Medicaid) and penalties (i.e. decreased Medicare/Medicaid reimbursements for covered patients to doctors who fail to use EMR's by 2015) for EMR/EHR adoption versus continued use of paper records as part of the Health Information Technology for Economic and Clinical Health (HITECH) Act, enacted as part of the American Recovery and Reinvestment Act of 2009.

One study estimates electronic medical records improve overall efficiency by 6% per year, and the monthly cost of an EMR may (depending on the cost of the EMR) be offset by the cost of only a few "unnecessary" tests or admissions.

One of the biggest players is in the industry is Allscripts. Allscripts provides innovative solutions that empower all stakeholders across the healthcare continuum to deliver world-class outcomes. The company's clinical, financial, connectivity and information solutions for hospitals, physicians and post acute organizations are the essential technologies that enable a connected healthcare community.

Allscripts is one of the largest companies focused exclusively on healthcare information technology, with over 5,500 employees and combined 2009 pro forma revenues of approximately $1.2 billion. They bring to market a complete portfolio of clinical, financial, analytics and connectivity solutions, and a client base of 180,000 physicians, 1,500 hospitals and 10,000 nursing homes, homecare agencies and other post acute organizations – the largest network in healthcare.

Since January of 2009, Allscripts (MDRX) has gone from trading around $5.00, to trading over $20.00!

Cerner Corp is one of the few medical software companies we found that is even bigger than Allscripts. Cerner is transforming healthcare by eliminating error, variance and waste for healthcare providers and consumers around the world. Cerner solutions optimize processes for healthcare organizations ranging from single-doctor practices to entire countries, for the pharmaceutical and medical device industries, and for the field of healthcare as a whole. Their solutions are licensed by more than 9,000 facilities worldwide.

Cerner had almost $2 Billion in revenues last year, but what’s most impressive is their overall growth.

Over the last year Cerner (CERN)has seen about a 76% increase in stock price trading currently at around $70.00!

Obviously when looking at an industry that is yielding growth like this our interest is immediately peaked.

When looking deeper in to EMR’s and medical software we discovered that jobs in this industry are currently booming, and in some cases considered “Recession proof”.

The challenge of streamlining patient care through digitized medical records, e-prescription programs, and online hospital communication, is just now gaining momentum, giving younger companies a chance to make inroads. The federal stimulus bill pledged $19 billion to the development of a health-information tracking system. Based on that level of funding, employment in the field is expected to grow by 18 percent between now and 2016, according to data from the Bureau of Labor Statistics. One up-and-comer: Phreesia, a New York City business that makes electronic patient check-in tablets for doctors offices, recently closed $11.5 million in Series C funding, and has secured $25 million in funding to date.

So we’re seeing the government make it beneficial to transition to EMR’s and they’re paying for it!

Picture walking in to a doctor’s office as a rep for an EMR company being able to sell them a solution that not only is paid for by the government, but also increases their reimbursments!

Even though EMR systems with a computerized provider order entry (CPOE) have existed for more than 30 years, fewer than 10 percent of hospitals as of 2006 have a fully integrated system.

This could mean that there is plenty of room for new companies to enter this market and see success very early on!

There is talk all over about EMR’s and other medical software can help improve diabetes’s care!

New research suggests that using electronic medical records instead of paper files could greatly improve care for diabetic patients by boosting communication.

Diabetic patients "did better and improved faster" at various kinds of medical clinics that had switched to e-records, said study author Dr. Randall D. Cebul, a professor of medicine at Case Western Reserve University in Cleveland. "The differences were rather remarkable."

Cebul said the findings are strong. He acknowledged, however, that clinics often failed to fully follow guidelines about care for diabetics, even when they used electronic records.

Converting to electronic records may seem like a slam dunk when it comes to patient care. Proponents say they make it easier for doctors to communicate with patients and with one another. The records are also supposed to cut down on medical errors by doing things like providing warnings about medication allergies.

The iPad could be the leading the tablet assisting the implementation of electronic medical software…

Physicians and medical professionals have been some of the earliest adopters and strongest supporters of the iPad, and many electronic medical record (EMR) vendors are responding to the increased demand by producing solutions that are iPad-compatible.

Medical software vendors are approaching iPad solutions in various ways, but the development efforts can be summarized into these three options:

-Native iPad EMRs. These solutions have been developed specifically for the iPad and its iOS operating system. They take full advantage of the operating system and iPad user interface. The downside is that they are limited in terms of availability – so you only have a few robust choices if you want a native iPad EMR.

Many of these iPad apps are really great software applications. One solution, Dr. Chrono, allows physicians to easily pull up previous history charts and electronically send prescriptions to pharmacies. Nimble, another native iPad EMR, includes a module that allows physicians to display medical images and actually mark on them via the touchscreen interface – an intuitive and useful application that is the type of design that we’ll most likely see in other, future touchscreen-compatible EMRs.

These applications are new, meaning they lack many of the complex feature sets that on-premise or web-based EMR solutions offer. It will take some time for these systems to develop the full functionality of the more traditional systems. They most certainly will, but they simply don’t have all that the other systems can offer today.

-Remote access EMRs. Many software vendors are porting their native EMR solutions to the iPad by the means of remote access utilities, such as Citrix. The benefit is that most systems can be ported to the iPad using this technology. The drawback, however, is that this approach is simply creating a “window” via the iPad to access these on-premise EMRs. Physicians invested in the iPad because of its operating system and design, which is lost in these remote access ports.

-Web-based EMRs. These EMRs are some of the most popular solutions for doctors seeking HITECH Act incentive funds. In addition, there are a large amount of solutions from software vendors offered in a web-based, software-as-as-service model. With many solutions to pick from, physicians can select the system that best fits their budgeting and practice needs. Web-based EMRs run through the physician’s web browser, and many solutions are optimized for Apple’s Safari. That’s perfect for the iPad, as Safari is the native iPad Internet browser.

Recent News:

CADUCEUS SOFTWARE SYSTEMS CORP. Financials

EDGAR Online Financials (Fri, Aug 26)

CADUCEUS SOFTWARE SYSTEMS CORP. Files SEC form 10-Q, Quarterly Report

EDGAR Online (Mon, Aug 22)

Caduceus Software Systems Inc., Provides General Facts and Premise for Its Caduceus MMS Software.

Business Wire (Tue, Aug 16)

CADUCEUS SOFTWARE SYSTEMS CORP. Files SEC form 10-K, Annual Report

EDGAR Online (Mon, Jul 11)

CADUCEUS SOFTWARE SYSTEMS CORP. Files SEC form 8-K, Changes in Control or Registrant, Change in Shell Company Status

EDGAR Online (Thu, Jun 9)

Management:

President, Secretary, Treasurer, Chief Executive Officer, Financial Officer

Derrick Gidden is a graduate from Conventry Technical College in Telecommunication and Electronic Engineering (Oct 1978) and the University of Wolverhampton where has obtained a Post Graduate in Training Management (July 1994) and has successfully completed a wide array of other business management, training, auditing, project management and information technology programs (May 1992 – February 2010).

For more than twenty five years, he has provided management consulting and business development services to a number of private, public service and voluntary companies/organizations.

Mr. Gidden’s entrepreneurship began with two business ventures, between March of 2003 and April of 2008, called Oracle Business Development Partnership (UK) Limited and The Property Investor Group (UK) Limited. While working for Oracle Business Development Partnership (UK), he provided business development consultancy to business communities across UK, in addition to offering specific consultancy on business planning/development and raising finance. His duties also included supporting companies for sustainability, growth and competitiveness with consultancy on sales/marketing, IT, technology,manufacturing and import/export. While working for The Property Investor Group (UK) Limited, Mr. Gidden provided relevant property investments to prospective investors.

Since April of 2010, Mr. Gidden has been a director of the Poet’s Wood

Management Services working in conjunction with Redrow Homes Midlands Ltd., one of the leading companies in the residential home construction sector in the United Kingdom. He is also a school governor at King Edward VI School which is one of the top selective grammar school in the United Kingdom.

---

GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY

We are engaged in the business of marketing and advertising companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.  FreePennyAlerts.com's sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by FreePennyAlerts.com or an offer or solicitation to buy or sell any security.  Neither the owner of FreePennyAlerts.com nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases.   It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. To review our complete disclaimer and additional information, please visit FreePennyAlerts.com. FreePennyAlerts.com makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.



Please be advised that FreePennyAlerts.com has been paid $1,300,000 by Fridaus inc. to perform promotional and advertising services for a one Month profile of Caduceus Software Systems Corp which services include the issuance of this release and the other opinions that we release concerning CSOC.   FreePennyAlerts.com has not investigated the background of Fridaus Inc., the hiring company. Anyone viewing this newsletter should assume the hiring party or affiliates of the hiring party own shares of CSOC of which they plan to liquidate, further understanding that the liquidation of those shares may or may not negatively impact the share price. FreePennyAlerts.com has received this amount as a production budget for advertising efforts and will retain amounts over and above the cost of production, copywriting services, mailing and other distribution expenses as a fee for our services. As such, our opinion is neither unbiased nor independent, and you should consider that when evaluating our statements regarding CSOC. FreePennyAlerts.com is owned by: FreePennyAlerts, LLC, 40 East Main Street, Suite 572, Newark, Delaware 19711.Questions regarding this release may be sent to Editor @ FreePennyAlerts.com.



Notice of Stock Price Movements and Volatility 

Viewers of this newsletter should understand that trading activity and stock prices  in many if not all cases tend to increase during the advertisement campaigns of the profiled companies and in many if not all cases tend to decrease thereafter. This tends to create above average volatility and price movements in the profiled company during the advertisement campaign that viewers should take into consideration at all times. Campaigns vary in length, and many are for short periods of time, typically less than a week.



Notice of Affiliated and Non-Affiliated Newsletters

FreePennyAlerts.com regularly shares research with two affiliated newsletters ("Affiliated Newsletters") whose services have been retained to profile Caduceus Software Systems Corp "CSOC" during FreePennyAlerts.com's profile period.  FreePennyAlerts regularly coordinates the timing of the dissemination of its research reports with the two Affiliated Newsletters. It is also possible that other newsletters or profiles have been created by sources we are unaware of. Viewers should take this into consideration when viewing any increased interest in Caduceus Software Systems Corp "CSOC".



Some of the content in this release contains f orward-looking information within the meaning of Section 27 A of the Securities Act of 1 993 and Section 21 E of the Securities Exchange Act of 1 934 including statements regarding expected continual growth of the profiled company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1 995 it is hereby noted that statements contained herein that look f orward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any f orward looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company's filings with the Securities and Exchange Commission. However, a company's past performance does not guarantee future results.



Generally, the information regarding a company profiled is provided from public sources which we believe to be reliable but is not guaranteed by us as being accurate. More information can be received from the advertised companies' websitewww.caduceusco.com.com    Further specific financial information, filings and disclosures as well as general investor information about the profiled company, advice to investors and other investor resources are available at the Securities and Exchange Commission ("SEC") website www.sec.gov and the Financial Industry Regulatory Authority ("FINRA") website atwww.finra.org    Any investment should be made only after consulting with a qualified investment advisor and reviewing the publicly available financial statement and other information about the company profiled and verifying that the investment is appropriate and suitable. FreePennyAlerts.com makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained in this release or on our website. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and FreePennyAlerts.com has no obligation to update any of the information provided. FreePennyAlerts.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions.



From time to time certain content in our releases or website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our releases and website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or penny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled in our release or on our website may not have approved certain or any statements within the website. FreePennyAlerts.com encourages viewers to supplement the information obtained from this release and our website with independent research and other professional advice. The content in this release is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data.



This release may provide hyperlinks to third party websites or access to third party content. FreePennyAlerts.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does FreePennyAlerts.com control, endorse, or guarantee any content found in such sites. By accessing, viewing, or using the website or communications originating from this release, you agree that FreePennyAlerts.com, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that FreePennyAlerts.com, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.



FreePennyAlerts.com uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties.



You agree to hold FreePennyAlerts.com, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of our website or the information in our press releases, profiles and opinions. You agree that use of our website is at your sole risk.  FreePennyAlerts.com disclaims all warranties of any kind, express or implied.



We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov  and/or then FINRA at: www.finra.org. In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/Investors/index.htm.